The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence

Advances in Therapy

Volumn 25, Issue 5, 2008, Pages 389-398

  Liu, Jian Min ^a,b   Mao, Bo Yong ^a   Hong, Sun ^a   Liu, Yan Hui ^a   Wang, Xiu Jie ^a  

^a SICHUAN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Extracellular matrix; Neurovasculature; Operative tissue injury; Paracrine factors; Recurrence; Stem cell niche; Surgery

Indexed keywords

CD133 ANTIGEN; INTERLEUKIN 6; SCLEROPROTEIN; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMELYSIN; VASCULOTROPIN;

ANGIOGENESIS; ASTROCYTOSIS; BRAIN CANCER; BRAIN SURGERY; BRAIN TUMOR STEM CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CELL INVASION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; HUMAN; NEURAL STEM CELL; PARACRINE SIGNALING; POSTOPERATIVE PERIOD; PROGNOSIS; REVIEW; BRAIN TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL NICHE; TUMOR RECURRENCE;

BRAIN NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; STEM CELL NICHE;

EID: 58749089674     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-008-0050-x     Document Type: Review

References (78)

1. Gonzalez J, Gilbert MR. Treatment of astrocytomas. Curr Opin Neurol. 2005;18:632-638.
2. Hentschel SJ, Lang FF. Current surgical management of glioblastoma. Cancer J. 2003;9:113-125.
3. Harbaugh KS, Black PM. Strategies in the surgical management of malignant gliomas. Semin Surg Oncol. 1998;14:26-33.
4. Olson JJ. Neurosurgical advances in the treatment of brain tumors. Curr Oncol Rep. 2000;2:434-437.
5. Toms SA, Ferson DZ, Sawaya R. Basic surgical techniques in the resection of malignant gliomas. J Neuro Oncol. 1999;42:215-226.
6. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1989;16:1405-1409.
7. Sneed PK, Gutin PH, Larson DA, et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys. 1994;29:719-727.
8. Aydin H, Sillenberg I, von Lieven H. Patterns of failure following CT-based 3-D irradiation for malignant glioma. Strahlenther Onkol. 2001;177:424-431.
9. Burger PC, Dubois PJ, Schold SC Jr, et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg. 1983;58:159-169.
10. Gaspar LE, Fisher BJ, Macdonald DR, et al. Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys. 1992;24:55-57.
11. Mitchell P, Ellison DW, Mendelow AD. Surgery for malignant gliomas: mechanistic reasoning and slippery statistics. Lancet Neurol. 2005;4:413-422.
12. Matsukado Y, MacCarty CS, Kernohan JW. The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. J Neurosurg. 1961;18:636-644.
13. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg. 1987;66:865-874.
14. Brower V. Search and destroy: Recent research exploits adult stem cells' attraction to cancer. J Natl Cancer Inst. 2005;97:414-416.
15. Burger PC, Heinz ER, Shibata T, Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg. 1988;68:698-704.
16. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21:1624-1636.
17. Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11:69-82.
18. Yang ZJ. Wechsler-Reya RJ. Hit 'em where they live: Targeting the cancer stem cell niche. Cancer Cell. 2007;11:3-5.
19. Diabira S, Morandi X. Gliomagenesis and neural stem cells: Key role of hypoxia and concept of tumor "neo-niche". Med Hypotheses. 2008;70:96-104.
20. Stichel CC, Müller HW. The CNS lesion scar: New vistas on an old regeneration barrier. Cell Tissue Res. 1998;294:1-9.
21. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci. 1997;20:570-577.
22. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia. 2002;39:193-206.
23. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396-401.
24. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A. 2003;100:15178-15183.
25. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A. 2004;101:781-786.
26. Shih AH, Holland EC. Notch signaling enhances nestin expression in gliomas. Neoplasia. 2006;8:1072-1082.
27. Kondo T. Brain cancer stem-like cells. Eur J Cancer. 2006;42:1237-1242.
28. Lee HY, Kléber M, Hari L, et al. Instructive role of Wnt/ beta-catenin in sensory fate specification in neural crest stem cells. Science. 2004;303:1020-1023.
29. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993;71:2585-2597.
30. Yu JS, Liu GT, Morris-Irvin D, Black KL. Glioblastoma cancer stem cells exhibit chemoresistance with overexpression of multidrug resistance gene BCRP-1: 894. Neurosurgery. 2005;57:428.
31. Li L, Xie T. Stem cell niche: Structure and function. Annu Rev Cell Dev Biol. 2005;21:605-631.
32. Conover JC, Notti RQ. The neural stem cell niche. Cell Tissue Res. 2008;331:211-224.
33. Jordan JD, Ma DK, Ming GL, Song H. Cellular niches for endogenous neural stem cells in the adult brain. CNS Neurol Disord Drug Targets. 2007;6:336-341.
34. Gilbertson RJ, Rich JN. Making a tumour's bed: Glioblastoma stem cells and the vascular niche. Nat Rev Cancer. 2007;7:733-736.
35. Lamszus K, Heese O, Westphal M. Angiogenesis-related growth factors in brain tumors. Cancer Treat Res. 2004;117:169-190.
36. Dunn IF, Heese O, Black PM. Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol. 2000;50:121-137.
37. Ramírez-Castillejo C, Sánchez-Sánchez F, Andreu-Agulló C, et al. Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci. 2006;9:331-339.
38. Leventhal C, Rafii S, Rafii D, Shahar A, Goldman SA. Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol Cell Neurosci. 1999;13:450-464.
39. Le Bras B, Barallobre MJ, Homman-Ludiye J, et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat Neurosci. 2006;9:340-348.
40. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol. 2003;200:429-447.
41. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol. 2004;36:1046-1069.
42. Friedlander DR, Zagzag D, Shiff B, et al. Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Res. 1996;56:1939-1947.
43. Knott JC, Mahesparan R, Garcia-Cabrera I, et al. Stimulation of extracellular matrix components in the normal brain by invading glioma cells. Int J Cancer. 1998;75:864-872.
44. Bouterfa H, Darlapp AR, Klein E, Pietsch T, Roosen K, Tonn JC. Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions. J Neurooncol. 1999;44:23-33.
45. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005;7:122-133.
46. Mentlein R, Held-Feindt J. Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J Neurochem. 2002;83:747-753.
47. Nagashima G, Suzuki R, Asai J, Fujimoto T. Immunohistochemical analysis of reactive astrocytes around glioblastoma: An immunohistochemical study of postmortem glioblastoma cases. Clin Neurol Neurosurg. 2002;104:125-131.
48. Teicher BA. Malignant cells, directors of the malignant process: Role of transforming growth factor-beta. Cancer Metastasis Rev. 2001;20:133-143.
49. Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem. 2002;277:49481-49487.
50. Barbero S, Bajetto A, Bonavia R, et al. Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann N Y Acad Sci. 2002;973:60-69.
51. Huff CA, Matsui W, Smith BD, Jones RJ. The paradox of response and survival in cancer therapeutics. Blood. 2006;107:431-434.
52. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300:1155-1159.
53. De Toni F, Racaud-Sultan C, Chicanne G, et al. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene. 2006;25:3113-3122.
54. Folkerth RD. Histologic measures of angiogenesis in human primary brain tumors. Cancer Treat Res. 2004;117:79-95.
55. Morgan R, Kreipke CW, Roberts G, Bagchi M, Rafols JA. Neovascularization following traumatic brain injury: Possible evidence for both angiogenesis and vasculogenesis. Neurol Res. 2007;29:375-381.
56. Frontczak-Baniewicz M, Walski M. New vessel formation after surgical brain injury in the rat's cerebral cortex I. Formation of the blood vessels proximally to the surgical injury. Acta Neurobiol Exp (Wars). 2003;63:65-75.
57. Liu L, Liu H, Jiao J, et al. Changes in circulating human endothelial progenitor cells after brain injury. J Neurotrauma. 2007;24:936-943.
58. Sköld MK, von Gertten C, Sandberg-Nordqvist AC, Mathiesen T, Holmin S. VEGF and VEGF receptor expression after experimental brain contusion in rat. J Neurotrauma. 2005;22:353-367.
59. Barbero S, Bonavia R, Bajetto A, et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signalregulated kinases 1/2 and Akt. Cancer Res. 2003;63:1969-1974.
60. Ghirnikar RS, Lee YL, He TR, Eng LF. Chemokine expression in rat stab wound brain injury. J Neurosci Res. 1996;46:727-733.
61. Fomchenko EI, Holland EC. Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment. Neurosurg Clin N Am. 2007;18:39-58.
62. Kulbatski I, Mothe AJ, Nomura H, Tator CH. Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma. Curr Drug Targets. 2005;6:111-126.
63. Szele FG, Alexander C, Chesselet MF. Expression of molecules associated with neuronal plasticity in the striatum after aspiration and thermocoagulatory lesions of the cerebral cortex in adult rats. J Neurosci. 1995;15:4429-4448.
64. Hatten ME, Liem RK, Shelanski ML, Mason CA. Astroglia in CNS injury. Glia. 1991;4:233-243.
65. Eddleston M, Mucke L. Molecular profile of reactive astrocytes. Implications for their role in neurologic disease. Neuroscience. 1993;54:15-36.
66. Carbonell WS, Mandell JW. Transient neuronal but persistent astroglial activation of ERK/MAP kinase after focal brain injury in mice. J Neurotrauma. 2003;20:327-336.
67. Hozumi I, Chiu FC, Norton WT. Biochemical and immunocytochemical changes in glial fibrillary acidic protein after stab wounds. Brain Res. 1990;524:64-71.
68. Müller FJ, Snyder EY, Loring JF. Gene therapy: Can neural stem cells deliver? Nat Rev Neurosci. 2006;7:75-84.
69. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M. Glutamate release promotes growth of malignant gliomas. Nat Med. 2001;7:1010-1015.
70. Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol. 2001;24:169-181.
71. Chang CY, Li MC, Liao SL, Huang YL, Shen CC, Pan HC. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. J Clin Neurosci. 2005;12:930-933.
72. Tate CC, Tate MC, LaPlaca MC. Fibronectin and laminin increase in the mouse brain after controlled cortical impact injury. J Neurotrauma. 2007;24:226-230.
73. Falo MC, Fillmore HL, Reeves TM, Phillips LL. Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J Neurosci Res. 2006;84:768-781.
74. Nishio T, Kawaguchi S, Yamamoto M, Iseda T, Kawasaki T, Hase T. Tenascin-C regulates proliferation and migration of cultured astrocytes in a scratch wound assay. Neuroscience. 2005;132:87-102.
75. McGraw J, Hiebert GW, Steeves JD. Modulating astrogliosis after neurotrauma. J Neurosci Res. 2001;63:109-115.
76. Aarum J, Sandberg K, Haeberlein SL, Persson MA. Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci U S A. 2003;100:15983-15988.
77. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000;97:12846-12851.
78. Salman H, Ghosh P, Kernie SG. Subventricular zone neural stem cells remodel the brain following traumatic injury in adult mice. Neurotrauma. 2004;21:283-292.